Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

计划入组 11 人 · 首次发布于 2009 年 12 月 17 日

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

计划入组 4 人 · 首次发布于 2008 年 8 月 20 日

Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

计划入组 19 人 · 首次发布于 2025 年 7 月 10 日

Tebentafusp(Kimmtrak)

aptamer-drug conjugate (uveal melanoma)

Metastatic melanoma(Asylia Diagnostics)

MELANOMA INSTITUTE AUSTRALIA

Australia

MELANOMA AND SKIN CANCER TRIALS LIMITED

Australia

DR. LYNN E. SPITLER, MD

United States

Subgroup Analysis of Phase 3 FOCUS Study Reveals Optimal Patient Selection for Melphalan/Hepatic Delivery System in Uveal Melanoma

Phase 3 Trial Initiates to Evaluate Kimmtrak in Non-Metastatic Uveal Melanoma

Novel Treatment Landscape Expands for Uveal Melanoma with Multiple Promising Therapies in Development